These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 555868)

  • 21. Membrane transport changes in an adriamycin-resistant murine leukemia cell line and in its sensitive parental cell line.
    Bose R; Lam HY
    Cancer Chemother Pharmacol; 1988; 21(1):14-8. PubMed ID: 3342461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
    Inaba M; Kobayashi H; Sakurai Y; Johnson RK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2200-3. PubMed ID: 445418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further characterization of drug-sensitivity and cross-resistance profiles of cloned cell lines of Adriamycin-sensitive and -resistant P388 leukemia.
    Seneviratne C; Goldenberg GJ
    Cancer Commun; 1989; 1(1):21-7. PubMed ID: 2640153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
    Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M
    J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring multidrug resistance using rhodamine 123.
    Kessel D
    Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1981 May; 41(5):1967-72. PubMed ID: 7214365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and -resistant P388 cells.
    Streeter DG; Johl JS; Gordon GR; Peters JH
    Cancer Chemother Pharmacol; 1986; 16(3):247-52. PubMed ID: 3457646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
    Johnson RK; Chitnis MP; Embrey WM; Gregory EB
    Cancer Treat Rep; 1978 Oct; 62(10):1535-47. PubMed ID: 709555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotype.
    Badiner GJ; Moy BC; Smith KS; Tarpley WG; Groppi VE; Bhuyan BK
    Br J Cancer; 1990 Sep; 62(3):378-84. PubMed ID: 2145026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R; Reiter W; Krishan A
    J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of antitumor agents by calcium channel blockers with special reference to cross-resistance patterns.
    Tsuruo T; Kawabata H; Nagumo N; Iida H; Kitatani Y; Tsukagoshi S; Sakurai Y
    Cancer Chemother Pharmacol; 1985; 15(1):16-9. PubMed ID: 4006044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circumvention of multidrug resistance in P388 murine leukemia cells by a novel inhibitor of cyclic AMP-dependent protein kinase, H-87.
    Miyamoto K; Wakusawa S; Nakamura S; Koshiura R; Otsuka K; Naito K; Hagiwara M; Hidaka H
    Cancer Lett; 1990 May; 51(1):37-42. PubMed ID: 2337896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
    Ramu A; Cohen L; Glaubiger D
    Cancer Res; 1984 May; 44(5):1976-80. PubMed ID: 6324993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells.
    Nogae I; Kikuchi J; Yamaguchi T; Nakagawa M; Shiraishi N; Kuwano M
    Br J Cancer; 1987 Sep; 56(3):267-72. PubMed ID: 3663474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium, calmodulin, and protein content of adriamycin-resistant and -sensitive murine leukemic cells.
    Nair S; Samy TS; Krishan A
    Cancer Res; 1986 Jan; 46(1):229-32. PubMed ID: 3940193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
    Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5'-Nucleotidase activity and arachidonate metabolism in doxorubicin sensitive and resistant P388 cells.
    Ramu A; Glaubiger D; Soprey P; Reaman GH; Feuerstein N
    Br J Cancer; 1984 Apr; 49(4):447-51. PubMed ID: 6324840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells.
    Adwankar MK; Chitnis MP
    Neoplasma; 1990; 37(1):31-6. PubMed ID: 2320178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Kessel D; Wilberding C
    Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of DMDP, a tiapamil analogue, on adriamycin efflux in adriamycin-resistant and -sensitive P388 cells.
    Radel S; Mayhew E; Rustum YM
    Anticancer Res; 1987; 7(6):1105-8. PubMed ID: 3442407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.